Will COVID Come Back? New Variant Predictions 2026

COVID-19 has not disappeared. The virus continues to circulate, mutate, and cause illness, even if it no longer dominates headlines. The question of whether a significant new wave or variant could disrupt life again is one that prediction markets actively trade. The answer offers both reassurance and caution.

What Prediction Markets Say

The prediction market consensus: COVID will continue to circulate and evolve, with a meaningful chance (25%) of a significant new variant emerging. However, the odds of a severe wave that overwhelms hospitals (8%) or triggers lockdowns (3%) are very low. The world has built enough immunity (through both infection and vaccination) to prevent a repeat of 2020-2021, barring a dramatically different variant.

Why a Severe COVID Resurgence Is Unlikely

1. Population Immunity Is High

Over 95% of the global population has some form of COVID immunity through prior infection, vaccination, or both. This "immunity wall" makes it much harder for any variant to cause the same level of severe disease and death as the original waves.

2. Treatment Options Have Improved

Antiviral medications (like Paxlovid), monoclonal antibodies, and improved hospital protocols have dramatically reduced COVID mortality. Even in a new wave, the case fatality rate would be much lower than in 2020.

3. Rapid Vaccine Updates

mRNA vaccine technology allows rapid updates to match new variants. If a dangerous variant emerges, updated boosters can be developed and deployed within months, not years.

4. Political Will for Lockdowns Is Gone

Even if a severe wave hits, the political appetite for lockdowns has essentially disappeared in most democracies. The 3% prediction market odds of any G7 lockdown reflect this reality. Future COVID management will rely on targeted measures, not broad shutdowns.

Why Some Risk Remains

1. Viral Evolution Is Unpredictable

SARS-CoV-2 continues to evolve, and there is no guarantee that future variants will be milder. A variant that significantly evades existing immunity while maintaining or increasing transmissibility could cause a serious wave, even in a highly immune population.

2. Immunity Waning

Protection from both infection and vaccination wanes over time, particularly against new variants. If a new variant emerges when population immunity is at a low point (typically in winter), the impact could be more severe than expected.

3. Complacency

Reduced surveillance, lower vaccination rates for boosters, and decreased public health infrastructure make it harder to detect and respond to a new wave quickly. The U.S. has significantly scaled back its COVID monitoring systems.

4. Recombination Risk

As multiple COVID variants co-circulate, there is a risk of recombination creating a novel variant with unexpected properties. This is a lower-probability but potentially high-impact scenario that prediction markets account for.

What About the Next Pandemic?

Beyond COVID, prediction markets also trade on the probability of an entirely new pandemic. The odds are modest (6% for 2026) but reflect genuine risk factors:

• H5N1 avian influenza: Circulating widely in birds and sporadically infecting mammals and humans. A mutation enabling efficient human-to-human transmission would be a serious threat.
• Novel pathogens: Spillover events from wildlife to humans are a constant risk, exacerbated by habitat destruction and climate change.
• Lab biosafety: The growth of high-containment research labs worldwide increases the risk of accidental release of engineered or collected pathogens.

How to Trade Health Prediction Markets

• Variant emergence contracts: Trade on whether new variants of concern are designated by specific dates.
• Hospitalization threshold contracts: Trade on whether hospitalization numbers exceed specific thresholds.
• Policy response contracts: Trade on government responses like lockdowns, travel restrictions, or vaccine mandates.
• Pharmaceutical contracts: Trade on vaccine approvals, antiviral developments, or public health funding decisions.

Frequently Asked Questions

Should I still get COVID boosters?

Public health authorities continue to recommend annual COVID boosters, particularly for high-risk groups. Prediction markets assign 85% probability to an updated booster recommendation in 2026. The booster decision is personal, but the scientific consensus supports continued vaccination.

Will there be another pandemic?

Prediction markets suggest a roughly 6% annual probability of a new pandemic declaration. Over a 10-year period, this compounds to a meaningful cumulative probability. Pandemic preparedness remains important even as COVID recedes.

Could COVID lockdowns happen again?

Extremely unlikely in G7 countries (3% probability). The political, economic, and social costs of lockdowns have made them a last resort that would only be considered in an extreme scenario with a much more lethal pathogen.

How do pandemics affect financial markets?

The 2020 COVID crash demonstrated that pandemics can cause rapid, severe market declines followed by strong recoveries (especially when stimulus measures are deployed). Prediction markets on pandemic risks offer a way to hedge portfolio exposure to these tail risks.